Implication of Gut Microbiota in Cardiovascular Diseases
Related Experiment Video
Updated: Dec 5, 2025

Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
Wenyi Zhou1,2, Yiyu Cheng1, Ping Zhu2
1Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
Insights
The gut microbiome influences cardiovascular diseases (CVDs) through metabolites and programmed cell death. Understanding this link may lead to new microbiota-targeted therapies for heart conditions.
Area of Science:
- Microbiology
- Cardiology
- Immunology
Background:
- Gut microbiota alterations are linked to cardiovascular diseases (CVDs).
- Microbial metabolites like TMAO, SCFAs, and BAs play roles in CVD development and prognosis.
- Programmed cell death pathways are emerging as crucial in microbiome-host interactions.
Purpose of the Study:
- To review the relationship between gut microbiota and cardiac disorders.
- To highlight the role of programmed cell death in this association.
- To explore microbiota-targeted therapeutic strategies for CVD management.
Main Methods:
- Literature review of recent studies.
- Summary of findings on gut microbiota and cardiac disorders.
- Focus on programmed cell death mechanisms.
Main Results:
- Gut microbiota composition is altered in various CVDs.
- Metabolites and programmed cell death are key mediators between gut microbes and heart health.
- Specific programmed cell death types (apoptosis, pyroptosis, ferroptosis) are implicated.
Conclusions:
- Gut microbiota significantly impacts cardiovascular health.
- Programmed cell death is a critical pathway in the gut-heart axis.
- Targeting the gut microbiome offers potential therapeutic avenues for CVDs.
Abstract:
Emerging evidence has identified the association between gut microbiota and various diseases, including cardiovascular diseases (CVDs). Altered intestinal flora composition has been described in detail in CVDs, such as hypertension, atherosclerosis, myocardial infarction, heart failure, and arrhythmia. In contrast, the importance of fermentation metabolites, such as trimethylamine N-oxide (TMAO), short-chain fatty acids (SCFAs), and secondary bile acid (BA), has also been implicated in CVD development, prevention, treatment, and prognosis. The potential mechanisms are conventionally thought to involve immune regulation, host energy metabolism, and oxidative stress. However, numerous types of programmed cell death, including apoptosis, autophagy, pyroptosis, ferroptosis, and clockophagy, also serve as a key link in microbiome-host cross talk. In this review, we introduced and summarized the results from recent studies dealing with the relationship between gut microbiota and cardiac disorders, highlighting the role of programmed cell death. We hope to shed light on microbiota-targeted therapeutic strategies in CVD management.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...

